• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

右门静脉结扎在诱导左肝残余肥大方面与门静脉栓塞同样有效。

Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant.

作者信息

Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N, Sibert A, Vilgrain V, Belghiti J

机构信息

Department of HPB Surgery, Beaujon Hospital (Assistance Publique-Hôpitaux de Paris), Bd Général Leclerc, Clichy, France.

出版信息

J Gastrointest Surg. 2008 Feb;12(2):297-303. doi: 10.1007/s11605-007-0410-x. Epub 2007 Nov 30.

DOI:10.1007/s11605-007-0410-x
PMID:18060468
Abstract

BACKGROUND

Aim of this retrospective study was to compare induction of left liver hypertrophy after right portal vein ligation (PVL) and right portal vein embolization (PVE) before right hepatectomy for liver metastases.

MATERIALS AND METHODS

Between 1998 and 2005, 18 patients underwent a PVE, whereas 17 patients underwent a PVL during a first stage laparotomy.

RESULTS

There was no complication related to PVE or PVL. After a similar interval time (7 +/- 3 vs 8 +/- 3 weeks), the increase of the left liver volume was similar between the two groups (35 +/- 38 vs 38 +/- 26%). After PVE and PVL, right hepatectomy was performed in 12 and 14 patients, respectively. Technical difficulties during the right hepatectomy were similar according to duration of procedure (6.4 +/- 1 vs 6.7 +/- 1 h, p = 0.7) and transfusion rates (33 vs 28%, p = 0.7). Mortality was nil in both groups, and morbidity rates were respectively 58% for the PVE group and 36% for the PVL group (p = 0.6).

CONCLUSION

Right PVL and PVE result in a comparable hypertrophy of the left liver. During the first laparotomy of a two-step liver resection, PVL can be efficiently and safely performed.

摘要

背景

本回顾性研究的目的是比较在肝转移瘤右肝切除术前,右门静脉结扎(PVL)和右门静脉栓塞(PVE)后左肝肥大的诱导情况。

材料与方法

1998年至2005年间,18例患者接受了PVE,而17例患者在一期剖腹手术中接受了PVL。

结果

未发生与PVE或PVL相关的并发症。在相似的间隔时间后(7±3对8±3周),两组左肝体积的增加相似(35±38对38±26%)。PVE和PVL后,分别有12例和14例患者接受了右肝切除术。根据手术时间(6.4±1对6.7±1小时,p = 0.7)和输血率(33%对28%,p = 0.7),右肝切除术中的技术难度相似。两组均无死亡病例,PVE组和PVL组的发病率分别为58%和36%(p = 0.6)。

结论

右PVL和PVE导致左肝肥大程度相当。在两步肝切除的首次剖腹手术中,PVL可以有效且安全地进行。

相似文献

1
Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant.右门静脉结扎在诱导左肝残余肥大方面与门静脉栓塞同样有效。
J Gastrointest Surg. 2008 Feb;12(2):297-303. doi: 10.1007/s11605-007-0410-x. Epub 2007 Nov 30.
2
Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.门静脉栓塞与门静脉结扎用于诱导未来肝剩余体积增大的比较
J Gastrointest Surg. 2002 Nov-Dec;6(6):905-13; discussion 913. doi: 10.1016/s1091-255x(02)00122-1.
3
Comparative study of right portal vein ligation versus embolisation for induction of hypertrophy in two-stage hepatectomy for multiple bilateral colorectal liver metastases.对比研究在两次肝切除术治疗多发双侧结直肠肝转移中,右门静脉结扎与栓塞对肝组织增生的诱导作用。
Eur J Surg Oncol. 2012 Jul;38(7):586-93. doi: 10.1016/j.ejso.2012.03.007. Epub 2012 May 4.
4
Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.门静脉结扎术作为在结直肠癌肝转移外科治疗中增加未来肝剩余体积的一种有效方法。
Arch Surg. 2008 Oct;143(10):978-82; discussion 982. doi: 10.1001/archsurg.143.10.978.
5
Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach.门静脉阻断后肝体积增加不足患者的挽救性肝实质离断术——ALPPS 方法的延伸。
Eur J Surg Oncol. 2013 Nov;39(11):1230-5. doi: 10.1016/j.ejso.2013.08.009. Epub 2013 Aug 29.
6
Two-Stage Hepatectomy and ALPPS for Advanced Bilateral Liver Metastases: a Tailored Approach Balancing Risk and Outcome.两阶段肝切除术和联合肝脏离断和门静脉结扎的分阶段肝切除术治疗进展期双侧肝转移瘤:一种平衡风险和预后的个体化方法。
J Gastrointest Surg. 2019 Dec;23(12):2391-2400. doi: 10.1007/s11605-019-04145-9. Epub 2019 Feb 28.
7
Future liver remnant growth after various portal vein embolization regimens: a quantitative comparison.不同门静脉栓塞方案后未来肝残余体积的增长:定量比较
Minim Invasive Ther Allied Technol. 2020 Apr;29(2):98-106. doi: 10.1080/13645706.2019.1582067. Epub 2019 Mar 1.
8
Radiological Simultaneous Portohepatic Vein Embolization (RASPE) Before Major Hepatectomy: A Better Way to Optimize Liver Hypertrophy Compared to Portal Vein Embolization.放射学同步门腔静脉栓塞术(RASPE)在肝切除术之前:与门静脉栓塞术相比,优化肝脏肥大的更好方法。
Ann Surg. 2020 Aug;272(2):199-205. doi: 10.1097/SLA.0000000000003905.
9
In situ split plus portal vein ligation (ISLT) - a salvage procedure following inefficient portal vein embolization to gain adequate future liver remnant volume prior to extended liver resection.原位劈裂加门静脉结扎术(ISLT)——一种在门静脉栓塞无效后进行的挽救性手术,目的是在扩大肝切除术前获得足够的未来肝残余体积。
BMC Surg. 2020 Apr 6;20(1):63. doi: 10.1186/s12893-020-00721-y.
10
Portal vein ligation versus portal vein embolization for induction of hypertrophy of the future liver remnant: A systematic review and meta-analysis.门静脉结扎术与门静脉栓塞术用于诱导未来肝残余组织肥大的系统评价和荟萃分析
Surg Oncol. 2017 Sep;26(3):257-267. doi: 10.1016/j.suronc.2017.05.001. Epub 2017 May 9.

引用本文的文献

1
Associating Liver Partition with Portal Vein Ligation and Staged Hepatectomy (ALPPS): Feasibility of Performing in Infants with Large Hepatic Tumor-Case Report.肝实质分隔联合门静脉结扎分期肝切除术(ALPPS):应用于巨大肝脏肿瘤婴儿的可行性——病例报告
Healthcare (Basel). 2025 Feb 21;13(5):460. doi: 10.3390/healthcare13050460.
2
Comprehensive Review of Future Liver Remnant (FLR) Assessment and Hypertrophy Techniques Before Major Hepatectomy: How to Assess and Manage the FLR.肝大部切除术前未来剩余肝脏(FLR)评估和肝体积增大技术的全面综述:如何评估和管理 FLR。
Ann Surg Oncol. 2024 Dec;31(13):9205-9220. doi: 10.1245/s10434-024-16108-9. Epub 2024 Sep 4.
3

本文引用的文献

1
Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.氟尿嘧啶联合奥沙利铂术前化疗后结直肠癌肝转移患者的肝脏组织学及手术结果
J Clin Oncol. 2006 Nov 1;24(31):4983-90. doi: 10.1200/JCO.2006.05.8156.
2
Improving resectability of hepatic colorectal metastases: expert consensus statement.提高肝结直肠癌转移灶的可切除性:专家共识声明
Ann Surg Oncol. 2006 Oct;13(10):1271-80. doi: 10.1245/s10434-006-9045-5. Epub 2006 Sep 6.
3
Portal vein ligation and partial hepatectomy differentially influence growth of intrahepatic metastasis and liver regeneration in mice.
Current Perspectives and Progress in Preoperative Portal Vein Embolization with Stem Cell Augmentation (PVESA).
干细胞增强的术前门静脉栓塞术(PVESA)的现状和进展。
Stem Cell Rev Rep. 2024 Jul;20(5):1236-1251. doi: 10.1007/s12015-024-10719-1. Epub 2024 Apr 13.
4
Right portal vein ligation is still relevant for left hemi-liver hypertrophy: results of a comparative study using a propensity score between right portal vein ligation and embolization.右门静脉结扎术对于左半肝肥大仍然具有相关性:使用倾向评分对右门静脉结扎术和栓塞术进行比较研究的结果。
Langenbecks Arch Surg. 2023 Dec 29;409(1):25. doi: 10.1007/s00423-023-03213-8.
5
Efficacy and safety of different options for liver regeneration of future liver remnant in patients with liver malignancies: a systematic review and network meta-analysis.不同方案促进肝脏恶性肿瘤患者剩余肝再生的疗效和安全性的系统评价和网络荟萃分析。
World J Surg Oncol. 2022 Dec 16;20(1):399. doi: 10.1186/s12957-022-02867-w.
6
Increased future liver function after modified associating liver partition and portal vein ligation/embolization for staged hepatectomy.改良联合肝脏分隔和门静脉结扎/栓塞分期肝切除术后肝脏功能的改善。
Acta Radiol Open. 2022 Oct 18;11(10):20584601221134951. doi: 10.1177/20584601221134951. eCollection 2022 Oct.
7
Current trends in regenerative liver surgery: Novel clinical strategies and experimental approaches.再生肝脏手术的当前趋势:新型临床策略与实验方法。
Front Surg. 2022 Sep 7;9:903825. doi: 10.3389/fsurg.2022.903825. eCollection 2022.
8
Liver growth prediction in ALPPS - A multicenter analysis from the international ALPPS registry.ALPPS 中的肝脏生长预测 - 来自国际 ALPPS 注册中心的多中心分析。
Liver Int. 2022 Dec;42(12):2815-2829. doi: 10.1111/liv.15287. Epub 2022 May 26.
9
Current strategies to induce liver remnant hypertrophy before major liver resection.在进行大型肝切除术前诱导肝剩余部分肥大的当前策略。
World J Hepatol. 2021 Nov 27;13(11):1629-1641. doi: 10.4254/wjh.v13.i11.1629.
10
Portal vein embolization: rationale, techniques, outcomes and novel strategies.门静脉栓塞:原理、技术、结果及新策略
Hepat Oncol. 2021 Sep 21;8(4):HEP42. doi: 10.2217/hep-2021-0006. eCollection 2021 Dec.
门静脉结扎和部分肝切除术对小鼠肝内转移瘤生长及肝再生的影响存在差异。
J Hepatol. 2006 Jul;45(1):35-42. doi: 10.1016/j.jhep.2006.02.020. Epub 2006 Apr 14.
4
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.化疗方案可预测肝结直肠癌转移灶手术后的脂肪性肝炎及90天死亡率的增加。
J Clin Oncol. 2006 May 1;24(13):2065-72. doi: 10.1200/JCO.2005.05.3074.
5
Hepatocyte morphology and kinetics after portal vein embolization.门静脉栓塞术后肝细胞的形态学与动力学
Br J Surg. 2006 Jun;93(6):745-51. doi: 10.1002/bjs.5332.
6
Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction.化疗不会损害右门静脉阻塞后左肝的肥大。
J Gastrointest Surg. 2006 Mar;10(3):365-70. doi: 10.1016/j.gassur.2005.09.001.
7
Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases.术前化疗对结直肠癌肝转移患者行大肝切除术风险的影响。
Ann Surg. 2006 Jan;243(1):1-7. doi: 10.1097/01.sla.0000193603.26265.c3.
8
The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy.术后第5天的“五五标准”:肝切除术后肝衰竭和死亡的准确预测指标。
Ann Surg. 2005 Dec;242(6):824-8, discussion 828-9. doi: 10.1097/01.sla.0000189131.90876.9e.
9
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?化疗期间肿瘤进展:多发性结直肠转移瘤肝切除的禁忌证?
Ann Surg. 2004 Dec;240(6):1052-61; discussion 1061-4. doi: 10.1097/01.sla.0000145964.08365.01.
10
A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases.一种两阶段肝切除术联合门静脉栓塞术,用于对初始不可切除的多发及双侧结直肠癌肝转移灶实现根治性切除。
Ann Surg. 2004 Dec;240(6):1037-49; discussion 1049-51. doi: 10.1097/01.sla.0000145965.86383.89.